Annual mass treatment with albendazole might eliminate human oesophagostomiasis from the endemic focus in northern Ghana

Tropical Medicine and International Health

Volumn 11, Issue 11, 2006, Pages 1759-1763

  Ziem, J B ^a,b   Olsen, A ^c   Magnussen, P ^c   Horton, J ^d   Spannbrucker, N ^e   Yelifari, L ^f   Nana Biritwum, K ^g   Polderman, A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY FOR DEVELOPMENT STUDIES   (Ghana)

^c DANISH BILHARZIASIS LABORATORY   (Denmark)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Board of Public Health Neuruppin   (Germany)

^f GHANA HEALTH SERVICE   (Ghana)

^g Health Research Unit Ghana Health Service   (Ghana)

Author keywords

Albendazole; Elimination; Human oesophagostomiasis

Indexed keywords

ALBENDAZOLE; IVERMECTIN;

DISEASE CONTROL; DISEASE TRANSMISSION; DISEASE TREATMENT; DRUG; PARASITE PREVALENCE; PARASITIC DISEASE;

ADULT; ARTICLE; CHILD; CIRCANNUAL RHYTHM; COLON; CONTROLLED STUDY; DISEASE CONTROL; DISEASE TRANSMISSION; ENDEMIC DISEASE; FECES ANALYSIS; FECES CULTURE; FEMALE; FILARIASIS; GHANA; HEALTH PROGRAM; HOOKWORM INFECTION; HUMAN; INFECTION CONTROL; INTESTINE WALL; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEMATODIASIS; PREVALENCE; SCREENING; STRONGYLOIDEA; ULTRASOUND;

ADULT; ALBENDAZOLE; ANTHELMINTICS; CHILD; ENDEMIC DISEASES; FEMALE; GHANA; HEALTH SURVEYS; HOOKWORM INFECTIONS; HUMANS; MALE; OESOPHAGOSTOMIASIS; PARASITE EGG COUNT; PREVALENCE; RURAL HEALTH;

AFRICA; GHANA; SUB-SAHARAN AFRICA; WEST AFRICA;

ANCYLOSTOMATOIDEA; OESOPHAGOSTOMUM;

EID: 33750315884     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2006.01730.x     Document Type: Article

References (9)

1. Gigase P, Baeta S, Kumar V & Brandt J (1987) Frequency of symptomatic human oesophagostomiasis (helminthoma) in northern Togo. In: Helminth Zoonoses (eds S Geerts, V Kumar & J Brandt) Martinus Nijhoff, Dordrecht, pp. 223-236.
2. de Gruijter JM, Gasser RB, Polderman AM, Asigri V & Dijkshoorn D (2005) High resolution DNA fingerprinting by AFLP to study the genetic variation among Oesophagostomum bifurcum (Nematoda) from human and non-human primates from Ghana. Parasitology 129, 1-9.
3. Haaf E & van Soest AH (1964) Oesophagostomiasis in man in north Ghana. Tropical and Geographical Medicine 16, 49-53.
4. Polderman AM, Anemana SD & Asigri V (1999) Human oesophagostomiasis: a regional public health problem in Africa [news]. Parasitology Today 15, 129-130.
5. Storey PA, Spannbrucker N, Yelifari L et al. (2001) Ultrasonographic detection and assessment of preclinical Oesophagostomum bifurcum-induced colonic pathology. Clinical Infectious Diseases 33, 166-170.
6. Yelifari L, Bloch P, Magnussen P et al. (2005) Distribution of human Oesophagostomum bifurcum, hookworm and Strongyloides infections on northern Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 32-38.
7. Ziem JB, Spannbrucker N, Magnussen P et al. (2005) Oesophagostomum bifurcum-induced nodular pathology in a highly endemic area of northern Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 417-422.
8. Ziem JB, Magnussen P, Olsen A et al. (2006) Impact of repeated mass treatment of human Oesophagostomum and hookworm infections in northern Ghana. Tropical Medicine and International Health 11, 1764-1772.
9. Ziem JB, Spannbrucker N, Olsen A et al. (in press) Mass treatment with albendazole reduces the prevalence and severity of Oesophagostomum-induced nodular pathology in northern Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 760-766.